Last reviewed · How we verify
urinary cotinine assesment — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
urinary cotinine assesment (urinary cotinine assesment) — Assistance Publique - Hôpitaux de Paris.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| urinary cotinine assesment TARGET | urinary cotinine assesment | Assistance Publique - Hôpitaux de Paris | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- urinary cotinine assesment CI watch — RSS
- urinary cotinine assesment CI watch — Atom
- urinary cotinine assesment CI watch — JSON
- urinary cotinine assesment alone — RSS
Cite this brief
Drug Landscape (2026). urinary cotinine assesment — Competitive Intelligence Brief. https://druglandscape.com/ci/urinary-cotinine-assesment. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing